4 ECTS credits
120 h study time
Offer 1 with catalog number 4023456ENR for all students in the 2nd semester
at
a (E) Master - advanced level.
- Semester
- 2nd semester
- Enrollment based on exam contract
- Impossible
- Grading method
- Grading (scale from 0 to 20)
- Can retake in second session
- Yes
- Enrollment Requirements
- Om een inschrijving te kunnen nemen voor 'Geïntegreerde farmacologie en farmacotherapie I
moet men :
Geslaagd zijn voor alle opleidingsonderdelen van de bacheloropleiding Farmaceutische wetenschappen EN moet men geslaagd of ingeschreven zijn voor ‘Farmacotherapie van de zelfzorg’, ‘Farmaceutische zorg & rationeel geneesmiddelengebruik’ en 'Farmaceutische technologie: receptuurkunde'
- Taught in
- Dutch
- Faculty
- Faculteit Geneeskunde en Farmacie
- Department
- Pharmaceutical and Pharmacological Sciences
- Educational team
- Stephane Steurbaut
Kristien De Paepe
Dimitri De Bundel
Santina Gorsen
Gunther Bal
Eline Tommelein
(course titular)
Ellen Cogge
Liesbeth Leemans
- Activities and contact hours
- 6 contact hours Lecture
15 contact hours Seminar, Exercises or Practicals
72 contact hours Independent or External Form of Study
- Course Content
In the course "Integrated practical pharmacology & pharmacotherapy" the student learns to integrate previously acquired knowledge from different courses within real-life practical cases. The course is offered via blended learning and is structured cyclically:
- Each student receives basic material that can be repeated or read through self-study
- Each student is evaluated just before the start of each WPO session on the topic of the WPO session
- During the WPO session, the students work in small groups on cases related to the topic of the WPO session
- After completion of the WPO session, the theme of the next WPO session is announced and the cycle starts again.
The course consists of six cycles.
- Additional info
.......
- Learning Outcomes
-
General competences
This course aims to give students the necessary skills in the integrated approach to practical cases.
Academic Learning Outcomes
1. The student learns to link knowledge and skills from various previous courses.
2. The student learns how to approach and analyze pharmacotherapeutic practical cases and to identify and solve possible drug-related problems.
Social learning outcomes
1. The student is able to communicate points for attention and / or solutions of drug-related problems to the patient and other care providers.
Personal learning outcomes
1. The student learns to cooperate within a group.
2. The student learns to test his own insights against those of others and is able to describe his own functioning within a group.
3. The student is able to reflect on his / her own performance.
4. The student can take responsibility for his / her own learning process.
- Grading
-
The final grade is composed based on the following categories:
Written Exam determines 50% of the final mark.
Other determines 50% of the final mark.
Within the Written Exam category, the following assignments need to be completed:
- Written exam
with a relative weight of 50
which comprises 50% of the final mark.
Within the Other category, the following assignments need to be completed:
- Continuous evaluation
with a relative weight of 50
which comprises 50% of the final mark.
- Additional info regarding evaluation
The assessment consists of the following categories: Evaluation part A “Presence and general attitude during the practical sessions”, Evaluation Part B “Permanent written evaluation of the practice sessions” and Evaluation part C “Written exam”.
Evaluation part A: Attendance during the practical sessions is mandatory. Absence must be justified by means of an official document.
-
- An unlawful absence during the practical sessions leads to failure to pass evaluation part A.
- In the case of a legitimate absence during a maximum of one practical session, the student must fulfil the test prior to the missed session session at another time during the semester.
- A legitimate absence for more than one day leads to failure to pass evaluation part A.
- Attitude during the WPO is evaluated through peer evaluation. The students evaluate each other's performance within the group via an online platform. The titular always has the last word and can decide to reinforce, attenuate, or even ignore the result of the peer assessment, if obtained scores prove to be unreliable. In principle, this decision will only be taken in exceptional cases, but will always be based on clear arguments, analyses and / or additional observations / conversations.
- Failure to pass evaluation part A means referral to the next academic year. Because different skills are tested in the course, this cannot be evaluated in the second examination period: a large part of the design and objectives of this course would be lost.
Evaluation part B: Permanent written evaluation of the practce sessions (50%)
- Each student is tested just before the start of each practice session regarding the topic of the practice session. The final result is the average of the tests taken.
- Failure to pass evaluation part B means a referral to the second examination period during which all tests within evaluation part B must be retaken.
Evaluation part C: The written exam (50%)
-
- The written exam consists of tackling practical cases on themes that were discussed in the WPO sessions.
- Failure to pass evaluation part C means a reference to the second examination period, in which only Evaluation Part B must be retaken.
Failure to pass evaluation part B or C in the second examination period means a reference to the next academic year, in which only evaluation part B or C respectively must be retaken.
- Allowed unsatisfactory mark
- The supplementary Teaching and Examination Regulations of your faculty stipulate whether an allowed unsatisfactory mark for this programme unit is permitted.
Academic context
This offer is part of the following study plans:
Master of Pharmaceutical Care: Standaard traject NIEUW (only offered in Dutch)
Master of Drug Development: Pharmacist (only offered in Dutch)